Gunnar Gislason

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

Jonas Bjerring Olesen, Gregory Y.H. Lip, Mona Hansen et al. · BMJ · 2011 · 1.4K citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +16

Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest

Mads Wissenberg, Freddy Lippert, Fredrik Folke et al. · JAMA · 2013 · 1.2K citations

Health Professions, Emergency Medical Services, Emergency Medicine +13

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

Jonas Bjerring Olesen, Gregory Y.H. Lip, Anne‐Lise Kamper et al. · New England Journal of Medicine · 2012 · 924 citations · Full text

Medicine, Cardiology, Neurology +14

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation

Morten Lock Hansen, Rikke Sørensen, Mette T. Clausen et al. · Archives of Internal Medicine · 2010 · 846 citations

Medicine, Cardiology, Pharmacotherapy +17